Table 4.
Frequency of use of specific medications included in ‘Other’ category for LOT1-LOT3
| Frequency | Percent (%) | |
|---|---|---|
| LOT 1 regimen | ||
| Carboplatin, paclitaxel | 29 | 5.2 |
| Paclitaxel | 28 | 5.0 |
| Carboplatin | 18 | 3.2 |
| Temozolomide | 14 | 2.5 |
| Bevacizumab | 12 | 2.2 |
| Cyclophosphamide, doxorubicin, vincristine | 9 | 1.6 |
| Sunitinib | 8 | 1.4 |
| Docetaxel | 8 | 1.4 |
| Etoposide | 7 | 1.3 |
| Ifosfamide | 7 | 1.3 |
| Etoposide, ifosfamide | 6 | 1.1 |
| Carboplatin, docetaxel | 6 | 1.1 |
| Irinotecan, temozolomide | 5 | 0.9 |
| Sorafenib | 5 | 0.9 |
| Gemcitabine, paclitaxel | 4 | 0.7 |
| Carboplatin, etoposide | 4 | 0.7 |
| Cyclophosphamide | 4 | 0.7 |
| Dacarbazine | 4 | 0.7 |
| Docetaxel, doxorubicin, gemcitabine | 4 | 0.7 |
| Bevacizumab, temozolomide | 3 | 0.5 |
| Bevacizumab, carboplatin, paclitaxel | 3 | 0.5 |
| Vincristine | 3 | 0.5 |
| Vinorelbine | 3 | 0.5 |
| Carboplatin, gemcitabine | 3 | 0.5 |
| Cyclophosphamide, dactinomycin, vincristine | 3 | 0.5 |
| Cyclophosphamide, doxorubicin, etoposide, ifosfamide, vincristine | 3 | 0.5 |
| Dacarbazine, doxorubicin | 3 | 0.5 |
| Eribulin | 3 | 0.5 |
| Gemcitabine, vinorelbine | 2 | 0.4 |
| Irinotecan | 2 | 0.4 |
| Irinotecan, temozolomide, vincristine | 2 | 0.4 |
| Carboplatin, irinotecan | 2 | 0.4 |
| Cyclophosphamide, etoposide | 2 | 0.4 |
| Cyclophosphamide, vinorelbine | 2 | 0.4 |
| Cyclophosphamide, dacarbazine, doxorubicin | 2 | 0.4 |
| Cyclophosphamide, doxorubicin, irinotecan, vincristine | 2 | 0.4 |
| Docetaxel, gemcitabine, pazopanib | 2 | 0.4 |
| Doxorubicin, gemcitabine | 2 | 0.4 |
| Doxorubicin, pazopanib | 2 | 0.4 |
| Etoposide, ifosfamide, methotrexate | 1 | 0.2 |
| Gemcitabine, ifosfamide | 1 | 0.2 |
| Gemcitabine, sunitinib | 1 | 0.2 |
| Ifosfamide, paclitaxel | 1 | 0.2 |
| Methotrexate | 1 | 0.2 |
| Pazopanib, sorafenib | 1 | 0.2 |
| Bevacizumab, irinotecan | 1 | 0.2 |
| Bevacizumab, irinotecan, temozolomide, vincristine | 1 | 0.2 |
| Bevacizumab, paclitaxel | 1 | 0.2 |
| Bevacizumab, docetaxel | 1 | 0.2 |
| Bevacizumab, doxorubicin | 1 | 0.2 |
| Temozolomide, topotecan, vincristine | 1 | 0.2 |
| Carboplatin, etoposide, irinotecan | 1 | 0.2 |
| Carboplatin, gemcitabine, paclitaxel | 1 | 0.2 |
| Carboplatin, methotrexate, paclitaxel | 1 | 0.2 |
| Carboplatin, epirubicin, paclitaxel | 1 | 0.2 |
| Cyclophosphamide, dacarbazine, doxorubicin, vincristine | 1 | 0.2 |
| Cyclophosphamide, doxorubicin | 1 | 0.2 |
| Cyclophosphamide, doxorubicin, etoposide, vincristine | 1 | 0.2 |
| Cyclophosphamide, doxorubicin, paclitaxel | 1 | 0.2 |
| Dacarbazine, gemcitabine | 1 | 0.2 |
| Dacarbazine, pazopanib | 1 | 0.2 |
| Dacarbazine, doxorubicin, gemcitabine | 1 | 0.2 |
| Dacarbazine, doxorubicin, ifosfamide | 1 | 0.2 |
| Dacarbazine, doxorubicin, methotrexate | 1 | 0.2 |
| Docetaxel, paclitaxel | 1 | 0.2 |
| Docetaxel, doxorubicin, gemcitabine, ifosfamide | 1 | 0.2 |
| Doxorubicin, gemcitabine, vinorelbine | 1 | 0.2 |
| Doxorubicin, ifosfamide, pazopanib | 1 | 0.2 |
| Doxorubicin, ifosfamide, vincristine | 1 | 0.2 |
| LOT 2 regimen | ||
| Methotrexate | 7 | 3.1 |
| Paclitaxel | 7 | 3.1 |
| Carboplatin, paclitaxel | 7 | 3.1 |
| Doxorubicin, ifosfamide | 5 | 2.2 |
| Gemcitabine, paclitaxel | 4 | 1.7 |
| Ifosfamide | 4 | 1.7 |
| Sorafenib | 4 | 1.7 |
| Vinorelbine | 4 | 1.7 |
| Dacarbazine, doxorubicin | 4 | 1.7 |
| Docetaxel | 4 | 1.7 |
| Bevacizumab | 3 | 1.3 |
| Carboplatin | 3 | 1.3 |
| Dacarbazine | 3 | 1.3 |
| Etoposide | 2 | 0.9 |
| Bevacizumab, paclitaxel | 2 | 0.9 |
| Bevacizumab, temozolomide | 2 | 0.9 |
| Bevacizumab, docetaxel, gemcitabine | 2 | 0.9 |
| Carboplatin, gemcitabine | 2 | 0.9 |
| Doxorubicin, gemcitabine | 2 | 0.9 |
| Eribulin | 2 | 0.9 |
| Etoposide, ifosfamide | 1 | 0.4 |
| Etoposide, ifosfamide, irinotecan, vincristine | 1 | 0.4 |
| Gemcitabine, irinotecan | 1 | 0.4 |
| Gemcitabine, pazopanib | 1 | 0.4 |
| Gemcitabine, vinorelbine | 1 | 0.4 |
| Irinotecan, temozolomide | 1 | 0.4 |
| Irinotecan, temozolomide, vincristine | 1 | 0.4 |
| Paclitaxel, pazopanib | 1 | 0.4 |
| Pazopanib, sunitinib | 1 | 0.4 |
| Sunitinib | 1 | 0.4 |
| Bevacizumab, dacarbazine | 1 | 0.4 |
| Bevacizumab, doxorubicin | 1 | 0.4 |
| Topotecan | 1 | 0.4 |
| Carboplatin, methotrexate, paclitaxel | 1 | 0.4 |
| Cyclophosphamide, etoposide | 1 | 0.4 |
| Cyclophosphamide, methotrexate | 1 | 0.4 |
| Cyclophosphamide, temozolomide, topotecan | 1 | 0.4 |
| Cyclophosphamide, topotecan | 1 | 0.4 |
| Cyclophosphamide, vincristine | 1 | 0.4 |
| Cyclophosphamide, dacarbazine, doxorubicin | 1 | 0.4 |
| Cyclophosphamide, dacarbazine, doxorubicin, vincristine | 1 | 0.4 |
| Cyclophosphamide, docetaxel | 1 | 0.4 |
| Cyclophosphamide, doxorubicin, etoposide, ifosfamide | 1 | 0.4 |
| Cyclophosphamide, doxorubicin, etoposide, ifosfamide, vincristine | 1 | 0.4 |
| Cyclophosphamide, doxorubicin, vincristine | 1 | 0.4 |
| Dacarbazine, gemcitabine | 1 | 0.4 |
| Dacarbazine, ifosfamide | 1 | 0.4 |
| Dacarbazine, doxorubicin, ifosfamide | 1 | 0.4 |
| Docetaxel, gemcitabine, paclitaxel | 1 | 0.4 |
| Docetaxel, gemcitabine, pazopanib | 1 | 0.4 |
| Docetaxel, doxorubicin, gemcitabine | 1 | 0.4 |
| Doxorubicin, gemcitabine, vinorelbine | 1 | 0.4 |
| Doxorubicin, paclitaxel | 1 | 0.4 |
| Doxorubicin, pazopanib | 1 | 0.4 |
| LOT 3 regimen | ||
| Vinorelbine | 4 | 4.5 |
| Gemcitabine | 3 | 3.4 |
| Paclitaxel | 2 | 2.3 |
| Cyclophosphamide, dactinomycin, vincristine | 2 | 2.3 |
| Cyclophosphamide, doxorubicin, vincristine | 2 | 2.3 |
| Docetaxel | 2 | 2.3 |
| Etoposide, ifosfamide | 1 | 1.1 |
| Etoposide, ifosfamide, irinotecan | 1 | 1.1 |
| Gemcitabine, irinotecan | 1 | 1.1 |
| Gemcitabine, methotrexate | 1 | 1.1 |
| Ifosfamide | 1 | 1.1 |
| Irinotecan, temozolomide | 1 | 1.1 |
| Irinotecan, vincristine | 1 | 1.1 |
| Sorafenib | 1 | 1.1 |
| Bevacizumab, gemcitabine, paclitaxel | 1 | 1.1 |
| Bevacizumab, cyclophosphamide, sorafenib | 1 | 1.1 |
| Carboplatin | 1 | 1.1 |
| Topotecan | 1 | 1.1 |
| Cyclophosphamide, topotecan | 1 | 1.1 |
| Cyclophosphamide, doxorubicin | 1 | 1.1 |
| Cyclophosphamide, doxorubicin, irinotecan, vincristine | 1 | 1.1 |
| Dacarbazine | 1 | 1.1 |
| Dacarbazine, pazopanib | 1 | 1.1 |
| Dacarbazine, vinorelbine | 1 | 1.1 |
| Dacarbazine, doxorubicin | 1 | 1.1 |